戻る
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)価格
2315.HK 株価推移チャート
BIOCYTOGEN-B (2315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$43.28
-0.55%
$-0.24
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$43
始値
$43.52
当日レンジ
$41 - $43.88
52週レンジ
$7.25 - $48.26
取引高
657.0K
平均取引高
1.0M
1株当たり利益(TTM)
0.37
配当利回り
--
時価総額
$4.6B
BIOCYTOGEN-Bとは何ですか？
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
